Astrogliosis and associated dysfunction of adenosine-homeostasis are pathological hallmarks of the epileptic brain and thought to contribute to seizure generation in epilepsy. We hypothesized that astrogliosis – an early component of the epileptogenic cascade – might be linked to focal seizure onset. To isolate the contribution of astrogliosis to ictogenesis from other pathological events involved in epilepsy, we used a minimalistic model of epileptogenesis in mice, based on a focal onset status epilepticus triggered by intraamygdaloid injection of kainic acid. We demonstrate acute neuronal cell loss restricted to the injected amygdala and ipsilateral CA3, followed three weeks later by focal astrogliosis and overexpression of the adenosine-metabolizing enzyme adenosine kinase (ADK). Using synchronous electroencephalographic recordings from multiple depth electrodes, we identify the KA-injected amygdala and ipsilateral CA3 as two independent foci for the initiation of non-synchronized electrographic subclinical seizures. Importantly, seizures remained focal and restricted to areas of ADK-overexpression. However, after systemic application of a non-convulsive dose of an adenosine A1-receptor antagonist, seizures in amygdala and CA3 immediately synchronized and spread throughout the cortex, leading to convulsive seizures. This focal seizure phenotype remained stable over at least several weeks. We conclude that astrogliosis via disruption of adenosine homeostasis per se and in the absence of any other overt pathology, is associated with the emergence of spontaneous recurrent subclinical seizures, which remain stable over space and time. A secondary event, here mimicked by brain-wide disruption of adenosine signaling, is likely required to turn pre-existing subclinical seizures into a clinical seizure phenotype.